Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy?
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
A consensus has yet to emerge whether deep brain stimulation (DBS) for treatment-refractory obsessive-compulsive disorder (OCD) can be considered an established therapy. In 2014, the World Society for Stereotactic and Functional Neurosurgery (WSSFN) published consensus guidelines stating that a therapy becomes established when “at least two blinded randomized controlled clinical trials from two different groups of researchers are published, both reporting an acceptable risk-benefit ratio, at least comparable with other existing therapies. The clinical trials should be on the same brain area for the same psychiatric indication.” The authors have now compiled the available evidence to make a clear statement on whether DBS for OCD is established therapy. Two blinded randomized controlled trials have been published, one with level I evidence (Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score improved 37% during stimulation on), the other with level II evidence (25% improvement). A clinical cohort study (N = 70) showed 40% Y-BOCS score improvement during DBS, and a prospective international multi-center study 42% improvement (N = 30). The WSSFN states that electrical stimulation for otherwise treatment refractory OCD using a multipolar electrode implanted in the ventral anterior capsule region (including bed nucleus of stria terminalis and nucleus accumbens) remains investigational. It represents an emerging, but not yet established therapy. A multidisciplinary team involving psychiatrists and neurosurgeons is a prerequisite for such therapy, and the future of surgical treatment of psychiatric patients remains in the realm of the psychiatrist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
The Levels of Evidence and Their Role in Evidence-Based Medicine
Burns, P. B., Rohrich, R. J., & Chung, K. C. (2011) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e318219c171 · Cited by 2,155
Perlmutter, J. S., & Mink, J. W. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112824 · Cited by 1,073
Treatment non-response in OCD: methodological issues and operational definitions
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416
Pallanti, S., & Quercioli, L. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.028 · Cited by 408
Luyten, L., Hendrickx, S., Raymaekers, S., Gabriëls, L., & Nuttin, B. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.124 · Cited by 264
Self-citationRules of evidence and clinical recommendations on the use of antithrombotic agents
Sackett, D. L. (1989) · Chest · doi:10.1378/chest.95.2.2s · Cited by 77
Cited by
Connectomic deep brain stimulation for obsessive-compulsive disorder
Baldermann, J. C., Schüller, T., Kohl, S., Voon, V., Li, N., Hollunder, B., Figee, M., Haber, S. N., Sheth, S. A., Mosley, P. E., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.07.010 · Cited by 118
Self-citationMoscarello, J. M., & Penzo, M. A. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01130-5 · Cited by 112
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Hollander, E., Kasper, S., Möller, H.-J., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2086296 · Cited by 84
Neuromodulation of OCD: a review of invasive and non-invasive methods
Kammen, A., Cavaleri, J., Lam, J., Frank, A. C., Mason, X., Choi, W., Penn, M., Brasfield, K., Van Noppen, B., Murray, S. B., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.909264 · Cited by 38
“Similarly, the World Society for Stereotactic and Functional Neurosurgeons (WSSFN) published consensus guidelines onDBS for OCD (155).”
BackgroundPrimum non nocere: The onus to characterize the potential harms of psychedelic treatment
Ghaznavi, S., Ruskin, J. N., Haggerty, S. J., King, F., & Rosenbaum, J. F. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230914 · Cited by 12
Metadata
- Authors
- Wu, H., Hariz, M., Visser-Vandewalle, V., Zrinzo, L., Coenen, V. A., Sheth, S. A., Bervoets, C., Naesström, M., Blomstedt, P., Coyne, T., Hamani, C., Slavin, K., Krauss, J. K., Kahl, K. G., Taira, T., Zhang, C., Sun, B., Toda, H., Schlaepfer, T., Chang, J. W., Régis, J., Schuurman, R., Schulder, M., Doshi, P., Mosley, P., Poologaindran, A., Lázaro-Muñoz, G., Pepper, J., Schechtmann, G., Fytagoridis, A., Huys, D., Gonçalves-Ferreira, A., D’Haese, P.-F., Neimat, J., Broggi, G., Vilela-Filho, O., Voges, J., Alkhani, A., Nakajima, T., Richieri, R., Djurfeldt, D., Fontaine, P., Martinez-Alvarez, R., Okamura, Y., Chandler, J., Watanabe, K., Barcia, J. A., Reneses, B., Lozano, A., Gabriëls, L., De Salles, A., Halpern, C. H., Matthews, K., Fins, J. J., & Nuttin, B.
- Venue
- Molecular Psychiatry
- Published
- 2020-11-03
- Volume
- 26
- Issue
- 1
- Pages
- 60-65
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W3096831886
- Cited by
- 115
- References
- 7
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy? https://app.cochat.ai/papers/10.1038/s41380-020-00933-x
- The paper
- Wu, H., Hariz, M., Visser-Vandewalle, V., Zrinzo, L., Coenen, V. A., Sheth, S. A., Bervoets, C., Naesström, M., Blomstedt, P., Coyne, T., Hamani, C., Slavin, K., Krauss, J. K., Kahl, K. G., Taira, T., Zhang, C., Sun, B., Toda, H., Schlaepfer, T., . . . Nuttin, B. (2021). Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy? Molecular Psychiatry. https://doi.org/10.1038/s41380-020-00933-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.